Publicly Traded Psychedelic Companies; Diversify Your Portfolio
Publicly Traded Psychedelic Companies – More investors currently engage in the stock exchange than ever before. Interestingly, one of the fastest and most promising sectors to invest in right now is psychedelics.
To be clear, many investors diversified their portfolio in cannabis stocks over the last decade, while many more feel they may have missed the Green Rush by not purchasing cannabis stocks sooner. Fortunately, there is still plenty of time to expand one’s portfolio to include the best new industry for investors: publicly traded psychedelic companies. However, the time is now. Right now. After all, it’s not very often that lightning strikes twice.
Why Investors Love Publicly Traded Psychedelic Companies
Investors who made wise moves in pharmaceuticals have made fortunes already. Notably, publicly traded psychedelic companies, in particular, may overwhelm many prominent players in the pharmaceutical industry. Importantly, industries most impacted will focus on treating conditions like Alzheimer’s Disease, dementia, depression, PTSD, traumatic brain injuries, and more.
Notably, the decriminalization efforts in Denver ultimately led to the full legalization of physician-assisted psychedelic therapy in Oregon. As such, the next gold rush (or Green Rush) is officially underway in the psychedelic space. To be clear, psychedelics include compounds like psilocybin, ayahuasca, DMT, LSD, peyote, MDMA, ketamine, 5-MeO-DMT. Notably, each of these substances contributes to the legal psychedelic landscape, and many publicly traded psychedelic companies are aware of this. In fact, many companies, both public and private, are currently conducting clinical trials on these various substances.
Inspiration Behind PsychedelCo
As someone who has successfully navigated the cannabis industry since 2015, I see all the same tendencies to follow the money train wherever it goes. This trend has inspired me to author this article to help shed light on the massive potential of publicly traded psychedelics companies. Groundbreaking discoveries are occurring at a phenomenal rate, and the results are astounding. Investors that place their money wisely in the ETF or other potentially lucrative companies could witness a substantial payoff in just a few years to come.
Importantly, diversifying a portfolio with psychedelic stocks, especially over these next few years, could be one of the wisest investments you can make. Notably, many publicly traded psychedelic companies are still in their infancy, so minimal investments could deliver maximum payout over time.
Notably, many investors put money into precious metals that, though incredibly safe, do not always have a substantial growth potential. That is, of course, unless these metals are particularly unique or collectible. Sure, the value of the raw materials will remain. However, they will not fluctuate to gain much beyond their value in weight unless the item itself is unique and rare. Finding such oddities is difficult, and often pricy to attain.
Cryptocurrency, a budding investment trend, also seems hot but is not backed by anything tangible. In other words, it could leave as quickly as it came, leaving investors with little to show if they don’t play the market right. In fact, I’ve also dabbled in cryptocurrency, but I wasn’t happy with the financial results or the negative impact on the environment of crypto mining.
The Future of Publicly Traded Psychedelic Companies
The psychedelic industry holds the potential to redefine many aspects of modern medicine completely. Notably, the compounds have grown naturally for centuries, being used by many cultures and indigenous people ever since. In fact, many have used psychedelics for medicinal and religious practices. However, we are only just beginning to realize their true therapeutic potential. Now that Wall Street is discovering the effects and dynamic properties of psychedelics, the average Joe should also take note. Shamans and alternative healers are already aware of the medicinal benefits; it’s time the public is, too.
Personally, I have experimented with psilocybin beginning in my youth and throughout my lifetime. However, only recently have concepts like micro-dosing emerged to highlight its broad therapeutic potential. People no longer take psychedelics just to “get fried.” Now, they can consume psychedelics to connect with their higher self and a higher purpose on this planet. As such, I firmly believe in the potential of psilocybin and other psychedelic compounds for entrepreneurs and creative business applications.